Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines.
Abstract
[INTRODUCTION] Normal and neoplastic breast tissues are comprised of heterogeneous populations of epithelial cells involving various degrees of maturation and differentiation. While cultured cell lines have been derived from both normal and malignant tissues, it remains unclear whether they retain a similar cellular heterogeneity as to that found within breast tissues.
[METHODS] We used 12 reduction mammoplasty tissues, 15 primary breast cancer tissues, and 20 human breast epithelial cell lines (16 cancer lines, 4 normal lines) to perform flow cytometry for CD44, CD24, epithelial cell adhesion molecule (EpCAM), and CD49f expression as well as immunohistochemistry, and in vivo tumor xenograft formation studies to extensively analyze the molecular and cellular characteristics of breast epithelial cell lineages.
[RESULTS] Human breast tissues contain four distinguishable epithelial differentiation states (two luminal phenotypes and two basal phenotypes) that differ on the basis of CD24, EpCAM and CD49f expression. Primary human breast cancer tissues also contain these four cellular states, but in altered proportions compared to normal tissues. In contrast, cultured cancer cell lines are enriched for rare basal and mesenchymal phenotypes, which are normally present in small numbers within human tissues. Similarly, cultured normal human mammary epithelial cell lines were enriched for rare basal and mesenchymal phenotypes that represent a minor fraction of cells within reduction mammoplasty tissues. Although normal human mammary epithelial cell lines exhibited features of bi-potent progenitor cells they were unable to differentiate into mature luminal breast epithelial cells.
[CONCLUSIONS] As a group breast cancer cell lines represent the heterogeneity of human breast tumors, but individually they exhibit increased lineage-restricted profiles that fall short of truly representing the intratumoral heterogeneity of individual breast tumors. Additionally, normal human mammary epithelial cell lines fail to retain much of the cellular diversity found in human breast tissues and are enriched for differentiation states that are a minority in breast tissues, although they do exhibit features of bi-potent basal progenitor cells. These findings suggest that collections of cell lines representing multiple cell types can be used to model the cellular heterogeneity of tissues.
[METHODS] We used 12 reduction mammoplasty tissues, 15 primary breast cancer tissues, and 20 human breast epithelial cell lines (16 cancer lines, 4 normal lines) to perform flow cytometry for CD44, CD24, epithelial cell adhesion molecule (EpCAM), and CD49f expression as well as immunohistochemistry, and in vivo tumor xenograft formation studies to extensively analyze the molecular and cellular characteristics of breast epithelial cell lineages.
[RESULTS] Human breast tissues contain four distinguishable epithelial differentiation states (two luminal phenotypes and two basal phenotypes) that differ on the basis of CD24, EpCAM and CD49f expression. Primary human breast cancer tissues also contain these four cellular states, but in altered proportions compared to normal tissues. In contrast, cultured cancer cell lines are enriched for rare basal and mesenchymal phenotypes, which are normally present in small numbers within human tissues. Similarly, cultured normal human mammary epithelial cell lines were enriched for rare basal and mesenchymal phenotypes that represent a minor fraction of cells within reduction mammoplasty tissues. Although normal human mammary epithelial cell lines exhibited features of bi-potent progenitor cells they were unable to differentiate into mature luminal breast epithelial cells.
[CONCLUSIONS] As a group breast cancer cell lines represent the heterogeneity of human breast tumors, but individually they exhibit increased lineage-restricted profiles that fall short of truly representing the intratumoral heterogeneity of individual breast tumors. Additionally, normal human mammary epithelial cell lines fail to retain much of the cellular diversity found in human breast tissues and are enriched for differentiation states that are a minority in breast tissues, although they do exhibit features of bi-potent basal progenitor cells. These findings suggest that collections of cell lines representing multiple cell types can be used to model the cellular heterogeneity of tissues.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 14 | |
| 해부 | mammary
|
유방 | dict | 3 | |
| 시술 | reduction mammoplasty
|
유방성형술 | dict | 2 | |
| 해부 | cellular
|
scispacy | 1 | ||
| 해부 | cell lines
|
scispacy | 1 | ||
| 해부 | epithelial cells
|
scispacy | 1 | ||
| 해부 | breast tissues
|
scispacy | 1 | ||
| 해부 | tissues
|
scispacy | 1 | ||
| 해부 | cancer lines
|
scispacy | 1 | ||
| 해부 | epithelial cell
|
scispacy | 1 | ||
| 해부 | breast epithelial cell
|
scispacy | 1 | ||
| 해부 | epithelial
|
scispacy | 1 | ||
| 해부 | cancer cell lines
|
scispacy | 1 | ||
| 해부 | mesenchymal
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 해부 | bi-potent progenitor cells
|
scispacy | 1 | ||
| 해부 | breast epithelial cells
|
scispacy | 1 | ||
| 해부 | breast cancer cell lines
|
scispacy | 1 | ||
| 합병증 | intratumoral
|
scispacy | 1 | ||
| 약물 | luminal
|
C0524462
Luminal region
|
scispacy | 1 | |
| 약물 | [INTRODUCTION] Normal
|
scispacy | 1 | ||
| 약물 | [RESULTS] Human breast tissues
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | primary breast cancer
|
scispacy | 1 | ||
| 질환 | cancer
|
C0006826
Malignant Neoplasms
|
scispacy | 1 | |
| 질환 | tumor
|
C0027651
Neoplasms
|
scispacy | 1 | |
| 질환 | breast cancer
|
C0006142
Malignant neoplasm of breast
|
scispacy | 1 | |
| 질환 | breast tumors
|
C1458155
Mammary Neoplasms
|
scispacy | 1 | |
| 질환 | malignant breast tissues
|
scispacy | 1 | ||
| 질환 | neoplastic breast tissues
|
scispacy | 1 | ||
| 질환 | malignant tissues
|
scispacy | 1 | ||
| 질환 | breast cancer tissues
|
scispacy | 1 | ||
| 질환 | EpCAM
→ epithelial cell adhesion molecule
|
scispacy | 1 | ||
| 질환 | tumor xenograft
|
scispacy | 1 | ||
| 질환 | breast tissues
|
scispacy | 1 | ||
| 기타 | human breast epithelial cell lines
|
scispacy | 1 | ||
| 기타 | CD44
|
scispacy | 1 | ||
| 기타 | CD24
|
scispacy | 1 | ||
| 기타 | CD49f
|
scispacy | 1 | ||
| 기타 | EpCAM
→ epithelial cell adhesion molecule
|
scispacy | 1 | ||
| 기타 | human breast cancer tissues
|
scispacy | 1 | ||
| 기타 | human tissues
|
scispacy | 1 | ||
| 기타 | human mammary epithelial cell lines
|
scispacy | 1 | ||
| 기타 | human breast tumors
|
scispacy | 1 | ||
| 기타 | human breast tissues
|
scispacy | 1 | ||
| 기타 | bi-potent basal progenitor cells
|
scispacy | 1 |
MeSH Terms
Animals; Antigens, Neoplasm; Biomarkers, Tumor; Breast; Breast Neoplasms; CD24 Antigen; Cell Adhesion Molecules; Cell Differentiation; Cell Line, Tumor; Epithelial Cell Adhesion Molecule; Epithelial Cells; Female; Gene Expression; Humans; Hyaluronan Receptors; Integrin alpha6; Mice; Mice, Inbred NOD; Mice, SCID
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.